Deutsche Märkte geschlossen

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
124,48-3,04 (-2,38%)
Börsenschluss: 04:00PM EDT
124,65 +0,17 (+0,14%)
Nachbörse: 07:40PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 373 3333
https://www.zimmerbiomet.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter18.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Ivan TornosCOO, President, CEO & Director2,72MN/A1975
Mr. Suketu P. UpadhyayCFO and Executive VP of Finance, Operations & Supply Chain2,01MN/A1969
Mr. Chad F. PhippsSenior VP, General Counsel & Secretary1,32M1,23M1972
Mr. Sang YiPresident of Asia Pacific1,38MN/A1962
Mr. Wilfred van ZuilenGroup President of Europe, Middle East & Africa1,47MN/A1970
Mr. Paul A. StellatoVP, Controller & Chief Accounting OfficerN/AN/A1975
Dr. Nitin Goyal M.D.Chief Science, Technology & Innovation OfficerN/AN/AN/A
Mr. Zeeshan TariqSenior VP & Chief Information OfficerN/AN/AN/A
Ms. Keri P. MattoxSVP and Chief Communications & Administration OfficerN/AN/AN/A
Mr. Zachary Ross Weiner CPADirector of Investor RelationsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Corporate Governance

Zimmer Biomet Holdings, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 6. Die grundlegenden Scores sind Audit: 2, Vorstand: 3, Shareholderrechte: 4, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.